1. 1) Hélène C. The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides. Anticancer Drug Des., 6, 569–584 (1991).
2. 2) Stein CA, Cohen JS. Oligodeoxynucleotides as inhibitors of gene expression: a review. Cancer Res., 48, 2659–2668 (1988).
3. Recent developments in the hammerhead ribozyme field
4. 4) Paddison PJ, Hannon GJ. RNA interference: the new somatic cell genetics? Cancer Cell, 2, 17–23 (2002).
5. 5) Ellington AD, Conrad R. Aptamers as potential nucleic acid pharmaceuticals. Biotechnol. Annu. Rev., 1, 185–214 (1995).